Desarrollo de nuevo dominio de transducción macromolecular con mejor permeabilidad celular y método de uso del mismo

Un péptido representado por la Fórmula 1: A1-A2-MTD en la que A1 es metionina (M, Met); A2 es un aminoácido seleccionado del grupo que consiste en arginina (R, Arg), histidina (H, His) y lisina (K, Lys), y un MTD tiene una secuencia de aminoácidos seleccionada del grupo que consiste en SEQ. ID. NO: 1 a 7. The present invention relates to an improved macromolecule transduction domain (MTD), which facilitates permeating the cell membrane of a biologically active molecule, having enhanced cell permeability. Specifically, an improved MTD according to the present invention, compared to an existing MTD, can transmit various types of biologically active molecule from inside the body and inside a test tube more effectively, and thus can be effectively used in a method to genetically alter a biologically active molecule so as to have cell permeability or in a method to transport a biologically active molecule into a cell, or the like. Additionally, the improved MTD can be very useful in development of new drugs and incrementally modified drugs as uses of the improved MTD are possible in drug delivery systems, recombinant protein vaccines or DNA/RNA therapeutic agents, gene or protein therapies, and pharmacologically or medically useful protein production or medical, pharmacological and pharmaceutical compositions.